These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25645500)

  • 21. Emerging treatments for pulmonary arterial hypertension.
    O'Callaghan DS
    Clin Respir J; 2008 Jul; 2(3):132-40. PubMed ID: 20298321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of pulmonary arterial hypertension.
    McLaughlin VV; Shah SJ; Souza R; Humbert M
    J Am Coll Cardiol; 2015 May; 65(18):1976-97. PubMed ID: 25953750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of acute pulmonary arterial hypertension.
    Hui-li G
    Cardiovasc Ther; 2011 Jun; 29(3):153-75. PubMed ID: 20560976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies.
    van Loon RL; Roofthooft MT; Delhaas T; van Osch-Gevers M; ten Harkel AD; Strengers JL; Backx A; Hillege HL; Berger RM
    Am J Cardiol; 2010 Jul; 106(1):117-24. PubMed ID: 20609658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.
    Theo Schermuly R; Ardeschir Ghofrani H; Weissmann N
    Curr Top Dev Biol; 2005; 67():251-84. PubMed ID: 15949537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
    Kaestner M; Schranz D; Warnecke G; Apitz C; Hansmann G; Miera O
    Heart; 2016 May; 102 Suppl 2():ii57-66. PubMed ID: 27053699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary arterial hypertension associated with connective tissue diseases].
    Legendre P; Mouthon L
    Presse Med; 2014 Sep; 43(9):957-69. PubMed ID: 25129118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of pulmonary arterial hypertension.
    Judge EP; Gaine SP
    Curr Opin Crit Care; 2013 Feb; 19(1):44-50. PubMed ID: 23242212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on pharmacotherapy for pulmonary hypertension.
    Prior DL; Adams H; Williams TJ
    Med J Aust; 2016 Sep; 205(6):271-6. PubMed ID: 27627939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in diagnosis and treatment of pulmonary arterial hypertension in neonates and children with congenital heart disease.
    Suesaowalak M; Cleary JP; Chang AC
    World J Pediatr; 2010 Feb; 6(1):13-31. PubMed ID: 20143207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic treatment of pulmonary arterial hypertension.
    Ramani GV; Gill S
    Curr Pharm Des; 2013; 19(22):3963-73. PubMed ID: 23228314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current drug targets and future therapy of pulmonary arterial hypertension.
    Ito T; Ozawa K; Shimada K
    Curr Med Chem; 2007; 14(6):719-33. PubMed ID: 17346158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary arterial hypertension in the pediatric age.
    Donti A; Formigari R; Ragni L; Manes A; Galiè N; Picchio FM
    J Cardiovasc Med (Hagerstown); 2007 Jan; 8(1):72-7. PubMed ID: 17255821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
    Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of pulmonary arterial hypertension].
    Jaïs X; Bonnet D
    Presse Med; 2010 Jun; 39 Suppl 1():1S22-32. PubMed ID: 20732614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging drugs for pulmonary hypertension.
    Girgis RE
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):71-85. PubMed ID: 20095920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.